About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Single Scope Staging of Lung Cancer With Endosonography

NCT02014324·9 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

(Suspected) NSCLC;
Indication for mediastinal nodal assessment;
Suspected mediastinal lymph nodes within reach of EBUS;
Age 18 years or older;
Clinically fit to undergo surgical resection of the lung tumor;
Provision of a written informed consent;

You may not be if

Mediastinal re-staging after neo-adjuvant treatment;
Indication for EUS other than mediastinal staging, eg a for malignancy
suspected left adrenal;
Active malignancy with a life expectancy of less than two years;
Former therapy for lung cancer (chemotherapy, radiotherapy or surgery);
Technical contraindication for EBUS or EUS (eg, esophagus stenosis);
Pregnancy;
Inability to consent;

The record

StatusCompleted

PhaseNo phase

Taking part215

StartedMay 2013

UpdatedOct 20, 2014

Conditions

Non Small Cell Lung Cancer (NSCLC)Indication Mediastinal Staging Complete Endosonography

Where9

Onze-Lieve-Vrouwen-Ziekenhuis
Aalst, Belgium
Universitair Ziekenhuis Leuven
Leuven, Belgium
Academic Medical Center
Amsterdam, North Holland, Netherlands

Clareo Health | Single Scope Staging of Lung Cancer With Endosonography